|

Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas

RECRUITINGN/ASponsored by Maastricht University Medical Center
Actively Recruiting
PhaseN/A
SponsorMaastricht University Medical Center
Started2024-09-02
Est. completion2027-09-02
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05851534

Summary

The goal of this stepped-wedge randomized controlled trial is to investigate whether implementation of a best practice program for preoperative optimisation (prehabilitation program) with a focus on screening, assessment, and intervention of 8 potentially (partly) modifiable risk factors in patients with (suspected) pancreatic cancer will improve outcome. The main questions it will aim to answer are: 1. Does a prehabilitation program improve the time to functional recovery after pancreatic surgery? 2. Does a prehabilitation program lead to a reduction in the Comprehensive Complication Index after pancreatic surgery?

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* All patients who are planned for a curative treatment with or without neoadjuvant treatment and elective pancreatic resection in one of the centres of the Dutch Pancreatic Cancer Group (i.e. all centres performing major pancreatic surgery)

Exclusion Criteria:

* age \< 18 years
* acute pancreatic resections (resection scheduled within two weeks)

Conditions5

CancerPancreas CancerPostoperative ComplicationsPrehabilitationSurgery

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.